Shin Poong Pharm.Co.Ltd. (019170) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shin Poong Pharm.Co.Ltd. (019170) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.42 Billion ≈ $2.31 Million USD) by net assets (₩270.73 Billion ≈ $183.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Shin Poong Pharm.Co.Ltd.'s balance sheet to measure how much of total assets are equity-financed.
Shin Poong Pharm.Co.Ltd. - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Shin Poong Pharm.Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shin Poong Pharm.Co.Ltd. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Shin Poong Pharm.Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shin Poong Pharm.Co.Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gajah Tunggal Tbk
JK:GJTL
|
0.068x |
|
Ioneer Ltd
AU:INR
|
-0.009x |
|
Cadiz Inc
NASDAQ:CDZI
|
-0.298x |
|
Nanjing Toua Hardware&Tools Co.Ltd.
SHE:301125
|
0.032x |
|
Praemium Ltd
AU:PPS
|
0.056x |
|
INNOX Advanced Materials Co.Ltd
KQ:272290
|
0.015x |
|
Thu Dau Mot Water JSC
VN:TDM
|
-0.009x |
|
Outbrain Inc
NASDAQ:OB
|
0.184x |
Annual Cash Flow Conversion Efficiency for Shin Poong Pharm.Co.Ltd. (2004–2025)
The table below shows the annual cash flow conversion efficiency of Shin Poong Pharm.Co.Ltd. from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see 019170 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩270.73 Billion ≈ $183.47 Million |
₩17.25 Billion ≈ $11.69 Million |
0.064x | +208.54% |
| 2024-12-31 | ₩258.09 Billion ≈ $174.90 Million |
₩-15.15 Billion ≈ $-10.27 Million |
-0.059x | +35.91% |
| 2023-12-31 | ₩270.78 Billion ≈ $183.51 Million |
₩-24.81 Billion ≈ $-16.81 Million |
-0.092x | -14.59% |
| 2022-12-31 | ₩330.76 Billion ≈ $224.15 Million |
₩-26.44 Billion ≈ $-17.92 Million |
-0.080x | +60.09% |
| 2021-12-31 | ₩354.56 Billion ≈ $240.28 Million |
₩-71.03 Billion ≈ $-48.13 Million |
-0.200x | -473.78% |
| 2020-12-31 | ₩374.33 Billion ≈ $253.68 Million |
₩20.06 Billion ≈ $13.60 Million |
0.054x | -42.08% |
| 2019-12-31 | ₩209.13 Billion ≈ $141.72 Million |
₩19.35 Billion ≈ $13.11 Million |
0.093x | -40.11% |
| 2018-12-31 | ₩207.48 Billion ≈ $140.61 Million |
₩32.05 Billion ≈ $21.72 Million |
0.154x | +219.87% |
| 2017-12-31 | ₩210.11 Billion ≈ $142.39 Million |
₩10.15 Billion ≈ $6.88 Million |
0.048x | -44.76% |
| 2016-12-31 | ₩216.85 Billion ≈ $146.96 Million |
₩18.96 Billion ≈ $12.85 Million |
0.087x | +72.25% |
| 2015-12-31 | ₩194.86 Billion ≈ $132.05 Million |
₩9.89 Billion ≈ $6.70 Million |
0.051x | +20285.40% |
| 2014-12-31 | ₩191.51 Billion ≈ $129.79 Million |
₩-48.16 Million ≈ $-32.64K |
0.000x | -100.42% |
| 2013-12-31 | ₩190.79 Billion ≈ $129.29 Million |
₩11.45 Billion ≈ $7.76 Million |
0.060x | -63.21% |
| 2012-12-31 | ₩188.73 Billion ≈ $127.90 Million |
₩30.79 Billion ≈ $20.87 Million |
0.163x | +2.16% |
| 2011-12-31 | ₩179.86 Billion ≈ $121.89 Million |
₩28.73 Billion ≈ $19.47 Million |
0.160x | +111.50% |
| 2010-12-31 | ₩150.39 Billion ≈ $101.92 Million |
₩11.36 Billion ≈ $7.70 Million |
0.076x | +11.76% |
| 2009-12-31 | ₩145.31 Billion ≈ $98.48 Million |
₩9.82 Billion ≈ $6.65 Million |
0.068x | -63.33% |
| 2008-12-31 | ₩127.93 Billion ≈ $86.70 Million |
₩23.57 Billion ≈ $15.97 Million |
0.184x | +114.71% |
| 2007-12-31 | ₩113.81 Billion ≈ $77.12 Million |
₩9.77 Billion ≈ $6.62 Million |
0.086x | -14.81% |
| 2006-12-31 | ₩106.28 Billion ≈ $72.02 Million |
₩10.71 Billion ≈ $7.25 Million |
0.101x | +99.59% |
| 2005-12-31 | ₩97.65 Billion ≈ $66.18 Million |
₩4.93 Billion ≈ $3.34 Million |
0.050x | -57.97% |
| 2004-12-31 | ₩87.36 Billion ≈ $59.20 Million |
₩10.49 Billion ≈ $7.11 Million |
0.120x | -- |
About Shin Poong Pharm.Co.Ltd.
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more